Dr. Fred R. Hirsch Departs IASLC CEO Role, Joins Mount Sinai...
Fred R. Hirsch, MD, resigned from his position of IASLC CEO at the end of October and has joined Mount Sinai Hospital in New...
Prophylactic Cranial Irradiation in Locally Advanced NSCLC Falls Flat
By John Armstrong, MD, FRCPI, DABR, FFRRCSI
RTOG 0214, a phase III randomized trial, is the biggest trial to date testing prophylactic cranial irradiation (PCI)...
Advocacy & Survivorship
After the Consultation: Social Media, Inter-Patient Communication, and Clinical Trials
By D. R. Camidge
Between March 2017 and April 2018, nearly 20,000 new members signed up for the Lung Cancer Survivors Support Community on...
Meeting News
Scientific Highlights from the IASLC Latin America Conference on Lung Cancer
By Edgardo S. Santos Castillero, MD, FACP
Five abstracts were presented at the Presidential Symposium of the 2018 IASLC Latin America Conference on Lung Cancer,...
